Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL

This publication has 41 references indexed in Scilit:

• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993
• The Biochemistry and Cell Biology of Antigen Processing and Presentation
  Annual Review of Immunology, 1993
• Peptides Naturally Presented by MHC Class I Molecules
  Annual Review of Immunology, 1993
• Cell Biology of Antigen Processing and Presentation to Major Histocompatibility Complex Class I Molecule-Restricted T Lymphocytes
  Published by Elsevier ,1992
• Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
  Nature, 1991
• Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
  Proceedings of the National Academy of Sciences, 1991
• Peptide-induced antiviral protection by cytotoxic T cells.
  Proceedings of the National Academy of Sciences, 1991
• Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule
  Nature, 1990
• Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.
  The Journal of Experimental Medicine, 1990
• Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
  The Journal of Experimental Medicine, 1989